Status:
COMPLETED
Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil)
Lead Sponsor:
Hospital Israelita Albert Einstein
Collaborating Sponsors:
Ministry of Health, Brazil
Conditions:
Covid19
SARS-CoV Infection
Eligibility:
All Genders
18+ years
Brief Summary
This is a registry-based cohort study of all adult patients (≥18 years) with confirmed or suspected SARS-CoV-2 infection. The main goal is to describe mortality incidence, demographic characteristics...
Detailed Description
Registry on characteristics and outcomes of hospitalized and non-hospitalized SARS-CoV2 infected patients in Brazil.
Eligibility Criteria
Inclusion
- Adult patients (≥18 years);
- Confirmed or suspected SARS-CoV2 infection
Exclusion
- Patient who expressed opposition to participation in the study
Key Trial Info
Start Date :
July 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2022
Estimated Enrollment :
1587 Patients enrolled
Trial Details
Trial ID
NCT04479488
Start Date
July 27 2020
End Date
December 30 2022
Last Update
March 9 2023
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Emergencia Dr. Daniel Houly
Arapiraca, Alagoas, Brazil
2
Alencar Serviços Médicos Ltda
Barbalha, Ceará, Brazil
3
Hospital Estadual Jayme dos Santos Neves
Serra, Espírito Santo, Brazil
4
Hospital Santa Rita de Cássia
Vitória, Espírito Santo, Brazil